Only two drops of blood needed: New test unveils the immune landscape of preterm babies

Preterm babies are fragile. This is especially true for infants born just six to seven months into a pregnancy. Called extremely preterm infants, these children essentially finish developing outside the uterus. Studying this vulnerable population is challenging because standard tests—such as blood draws—can be life-threatening for these small patients who have too little blood to support the amount needed in standard assays.

Liver cancer study finds optimal timing for transplants after immunotherapy

Hepatocellular carcinoma (HCC) represents about 80 to 90% of cases of primary liver cancer. On a global level, 905,700 new cases and 830,200 deaths were registered in 2020, according to the World Health Organization. In Switzerland, the Statistics Office lists 960 new cases and 720 deaths every year. HCC is the third cause of death due to cancer in the world and fifth in Switzerland.

Study provides greater reassurance for people at risk of inherited heart disease

If you’ve lost a family member prematurely to heart disease, greater reassurance about your risk of suffering the same fate is critical. That’s why a high-powered randomized controlled study led by the Baker Heart and Diabetes Institute that followed patients over three years has confirmed how we can better manage people who sit in the precarious intermediate risk zone, where they can often be overlooked.